Synopsys, Inc. $SNPS Shares Bought by Robeco Institutional Asset Management B.V.

Key Points

• Robeco Institutional Asset Management B.V. significantly increased its stake in Synopsys, Inc. by 302.3% during the second quarter, owning approximately $92 million worth of shares.
• Company insiders have been active, with Synopsys Director Robert G. Painter purchasing 350 shares and CAO Sudhindra Kankanwadi selling nearly 10,000 shares, indicating a mix of confidence and liquidity among executives.
• Analyst sentiment is mixed with multiple brokerages lowering price targets, including Bank of America reducing its target from $625 to $525, presenting a cautious outlook for the stock.

Robeco Institutional Asset Management B.V. raised its holdings in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 302.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 179,624 shares of the semiconductor company's stock after purchasing an additional 134,979 shares during the period. Robeco Institutional Asset Management B.V. owned about 0.12% of Synopsys worth $92,090,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of SNPS. Brighton Jones LLC grew its holdings in Synopsys by 5.7% in the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company's stock valued at $447,000 after purchasing an additional 50 shares during the period. HBW Advisory Services LLC grew its holdings in Synopsys by 11.8% in the first quarter. HBW Advisory Services LLC now owns 607 shares of the semiconductor company's stock valued at $260,000 after purchasing an additional 64 shares during the period. Fulton Bank N.A. grew its holdings in Synopsys by 16.4% in the first quarter. Fulton Bank N.A. now owns 1,697 shares of the semiconductor company's stock valued at $728,000 after purchasing an additional 239 shares during the period. Hennion & Walsh Asset Management Inc. boosted its stake in shares of Synopsys by 1.2% in the first quarter. Hennion & Walsh Asset Management Inc. now owns 6,163 shares of the semiconductor company's stock worth $2,643,000 after acquiring an additional 76 shares during the last quarter. Finally, SeaCrest Wealth Management LLC acquired a new stake in shares of Synopsys in the first quarter worth approximately $221,000. 85.47% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Synopsys news, Director Robert G. Painter bought 350 shares of Synopsys stock in a transaction on Thursday, September 11th. The shares were bought at an average price of $425.44 per share, for a total transaction of $148,904.00. Following the completion of the transaction, the director directly owned 2,291 shares of the company's stock, valued at $974,683.04. This trade represents a 18.03% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of Synopsys stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $500.90, for a total value of $4,945,385.70. Following the completion of the sale, the chief accounting officer owned 20,520 shares in the company, valued at $10,278,468. This represents a 32.48% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 30,894 shares of company stock worth $16,760,783 over the last ninety days. Company insiders own 0.62% of the company's stock.

Synopsys Price Performance

NASDAQ:SNPS opened at $471.14 on Friday. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52. The company has a market capitalization of $87.51 billion, a P/E ratio of 36.98, a P/E/G ratio of 5.39 and a beta of 1.10. The stock's fifty day moving average is $561.80 and its two-hundred day moving average is $509.25.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on SNPS. Bank of America reaffirmed an "underperform" rating and issued a $525.00 price target (down from $625.00) on shares of Synopsys in a research note on Wednesday, September 10th. KeyCorp lowered their price target on Synopsys from $660.00 to $590.00 and set an "overweight" rating on the stock in a research note on Wednesday, September 10th. Citigroup lowered Synopsys from a "neutral" rating to an "underperform" rating in a research note on Wednesday, September 10th. Wall Street Zen lowered Synopsys from a "hold" rating to a "sell" rating in a research note on Saturday, September 13th. Finally, Baird R W lowered Synopsys from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, September 10th. Eleven research analysts have rated the stock with a Buy rating, four have given a Hold rating and four have given a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $575.31.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.